Literature DB >> 21822699

Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy.

Barbara Borroni1, Andrea Pilotto, Cristian Bonvicini, Silvana Archetti, Antonella Alberici, Andrea Lupi, Massimo Gennarelli, Alessandro Padovani.   

Abstract

Mutations within Presenilin 1 (PSEN1) represent the most common cause of monogenic Alzheimer Disease (AD). The clinical phenotype is highly variable, even if early onset disease with an autosomal dominant pattern of inheritance and presenting memory deficits usually occur. In the present work, we described the case of a late-onset AD patient, without any positive family history for dementia, and associated with seizures and behavioural symptoms. Structural and functional neuroimaging showed frontotemporal changes without posterior biparietal brain abnormalities. Cerebrospinal analysis was consistent with AD pattern, with decreased Aβ42 and increased Tau and phospho-Tau. A novel pathogenetic mutation within PSEN1 gene was detected within exon 8, leading to a substitution from arginine to tryptophan (AGG > TGG: R377W), affecting a splice junction and protein function. The case herein reported further confirms the heterogeneity of PSEN1 mutations and the need to take into account genetic screening in those cases with atypical presentation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21822699     DOI: 10.1007/s10072-011-0714-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  12 in total

1.  Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.

Authors:  D M Mann; S M Pickering-Brown; A Takeuchi; T Iwatsubo
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

2.  The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.

Authors:  T Gómez-Isla; W B Growdon; M J McNamara; D Nochlin; T D Bird; J C Arango; F Lopera; K S Kosik; P L Lantos; N J Cairns; B T Hyman
Journal:  Brain       Date:  1999-09       Impact factor: 13.501

3.  A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years.

Authors:  T Wisniewski; W K Dowjat; J D Buxbaum; O Khorkova; S Efthimiopoulos; J Kulczycki; W Lojkowska; J Wegiel; H M Wisniewski; B Frangione
Journal:  Neuroreport       Date:  1998-01-26       Impact factor: 1.837

4.  Dementia, delusions and seizures: storage disease or genetic AD?

Authors:  A Alberici; C Bonato; B Borroni; M Cotelli; F Mattioli; G Binetti; M Gennarelli; M D Luca; A Simonati; D Perani; P Rossini; A Padovani
Journal:  Eur J Neurol       Date:  2007-09       Impact factor: 6.089

5.  Apolipoprotein E genotype and Alzheimer's disease. Alzheimer's Disease Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1993-09-18       Impact factor: 79.321

6.  Early-onset Alzheimer's disease with presenilin-1 M139V mutation: clinical, neuropsychological and neuropathological study.

Authors:  A J Larner; D G du Plessis
Journal:  Eur J Neurol       Date:  2003-05       Impact factor: 6.089

Review 7.  Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer's disease: an update.

Authors:  Andrew J Larner; Mark Doran
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

8.  Presenilin 1 mutation in an african american family presenting with atypical Alzheimer dementia.

Authors:  Gregory A Rippon; Richard Crook; Matthew Baker; Elizabeth Halvorsen; Steven Chin; Michael Hutton; Henry Houlden; John Hardy; Timothy Lynch
Journal:  Arch Neurol       Date:  2003-06

9.  Early-onset Alzheimer's disease with a de novo mutation in the presenilin 1 gene.

Authors:  M P Golan; M Styczyńska; K Jóźwiak; J Walecki; A Maruszak; J Pniewski; R Lugiewicz; S Filipek; C Zekanowski; M Barcikowska
Journal:  Exp Neurol       Date:  2007-09-05       Impact factor: 5.330

10.  Early onset familial Alzheimer's disease: Mutation frequency in 31 families.

Authors:  J C Janssen; J A Beck; T A Campbell; A Dickinson; N C Fox; R J Harvey; H Houlden; M N Rossor; J Collinge
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

View more
  8 in total

1.  Comparison of clinical characteristics between familial and non-familial early onset Alzheimer's disease.

Authors:  Aditi Joshi; John M Ringman; Albert S Lee; Kevin O Juarez; Mario F Mendez
Journal:  J Neurol       Date:  2012-03-30       Impact factor: 4.849

2.  Familial frontotemporal dementia-associated presenilin-1 c.548G>T mutation causes decreased mRNA expression and reduced presenilin function in knock-in mice.

Authors:  Hirotaka Watanabe; Dan Xia; Takahisa Kanekiyo; Raymond J Kelleher; Jie Shen
Journal:  J Neurosci       Date:  2012-04-11       Impact factor: 6.167

Review 3.  Biomarker modelling of early molecular changes in Alzheimer's disease.

Authors:  Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jonathan M Schott; Henrik Zetterberg
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

4.  Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.

Authors:  Brian J O'Roak; Laura Vives; Wenqing Fu; Jarrett D Egertson; Ian B Stanaway; Ian G Phelps; Gemma Carvill; Akash Kumar; Choli Lee; Katy Ankenman; Jeff Munson; Joseph B Hiatt; Emily H Turner; Roie Levy; Diana R O'Day; Niklas Krumm; Bradley P Coe; Beth K Martin; Elhanan Borenstein; Deborah A Nickerson; Heather C Mefford; Dan Doherty; Joshua M Akey; Raphael Bernier; Evan E Eichler; Jay Shendure
Journal:  Science       Date:  2012-11-15       Impact factor: 47.728

5.  EpilepsyGene: a genetic resource for genes and mutations related to epilepsy.

Authors:  Xia Ran; Jinchen Li; Qianzhi Shao; Huiqian Chen; Zhongdong Lin; Zhong Sheng Sun; Jinyu Wu
Journal:  Nucleic Acids Res       Date:  2014-10-16       Impact factor: 19.160

6.  PSEN1 Compound Heterozygous Mutations Associated with Cerebral Amyloid Angiopathy and Cognitive Decline Phenotype.

Authors:  Ilaria Palmieri; Marialuisa Valente; Lisa Maria Farina; Simone Gana; Brigida Minafra; Roberta Zangaglia; Orietta Pansarasa; Daisy Sproviero; Alfredo Costa; Claudio Pacchetti; Anna Pichiecchio; Stella Gagliardi; Cristina Cereda
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 7.  Clinical, biological, and imaging features of monogenic Alzheimer's Disease.

Authors:  Andrea Pilotto; Alessandro Padovani; Barbara Borroni
Journal:  Biomed Res Int       Date:  2013-11-27       Impact factor: 3.411

8.  Genetic counselling and testing for inherited dementia: single-centre evaluation of the consensus Italian DIAfN protocol.

Authors:  Anna Mega; Samantha Galluzzi; Cristian Bonvicini; Silvia Fostinelli; Massimo Gennarelli; Cristina Geroldi; Orazio Zanetti; Luisa Benussi; Emilio Di Maria; Giovanni B Frisoni
Journal:  Alzheimers Res Ther       Date:  2020-11-17       Impact factor: 6.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.